The Effect of Testosterone Replacement on Glycemic Control in Hypogonadal Men with Type 2 Diabetes Mellitus

被引：0
|
作者：
Lee, Hong S.
Bahn, Gideon
Azad, Nasrin
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2360-PO
引用
收藏
页码：A627 / A627
页数：1
相关论文
共 50 条
  • [1] Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus
    Shigehara, Kazuyoshi
    Konaka, Hiroyuki
    Kato, Yuki
    Iijima, Masashi
    Nakashima, Kazufumi
    Kawaguchi, Shohei
    Nohara, Takahiro
    Izumi, Kouji
    Namiki, Mikio
    Mizokami, Atsushi
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2019, 31 (01) : 25 - 30
  • [2] Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus
    Kazuyoshi Shigehara
    Hiroyuki Konaka
    Yuki Kato
    Masashi Iijima
    Kazufumi Nakashima
    Shohei Kawaguchi
    Takahiro Nohara
    Kouji Izumi
    Mikio Namiki
    Atsushi Mizokami
    [J]. International Journal of Impotence Research, 2019, 31 : 25 - 30
  • [3] The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes
    Groti, Kristina
    Zuran, Ivan
    Antonic, Blaz
    Forsnaric, Lidija
    Pfeifer, Marija
    [J]. AGING MALE, 2018, 21 (03): : 158 - 169
  • [4] Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports
    Saad, Farid
    Yassin, Aksam
    Almehmadi, Yousef
    Doros, Gheorghe
    Gooren, Louis
    [J]. AGING MALE, 2015, 18 (03): : 164 - 168
  • [5] The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes
    Kapoor, D.
    Clarke, S.
    Stanworth, R.
    Charmer, K. S.
    Jones, T. H.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (05) : 595 - 602
  • [6] Cardiovascular benefits and risks of testosterone replacement therapy in hypogonadal men with type 2 diabetes mellitus and/or the metabolic syndrome: a systematic review
    Le Minh Quang
    Kalhan, Atul
    [J]. BRITISH JOURNAL OF DIABETES, 2018, 18 (04): : 141 - 146
  • [7] Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
    Jones, T. Hugh
    Arver, Stefan
    Behre, Hermann M.
    Buvat, Jacques
    Meuleman, Eric
    Moncada, Ignacio
    Morales, Antonio Martin
    Volterrani, Maurizio
    Yellowlees, Ann
    Howell, Julian D.
    Channer, Kevin S.
    [J]. DIABETES CARE, 2011, 34 (04) : 828 - 837
  • [8] Glycemic benefits with adherence to testosterone therapy in men with hypogonadism and type 2 diabetes mellitus
    Jenkins, Craig R.
    Rittel, Alex
    Sturdivant, Rodney X.
    Wan, Jen
    Clerc, Philip G.
    Manning, Evan
    Jenkins, Lydia M.
    Wardian, Jana L.
    Graybill, Sky D.
    [J]. ANDROLOGY, 2021, 9 (04) : 1076 - 1085
  • [9] Serum testosterone in Nigerian men with type 2 diabetes mellitus and its relationship with insulin sensitivity and glycemic control
    Sepu, Ngamariju
    Adeleye, Jokotade O.
    Kuti, Modupe O.
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2021, 113 (03) : 285 - 293
  • [10] Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
    Kapoor, D.
    Goodwin, E.
    Channer, K. S.
    Jones, T. H.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (06) : 899 - 906
12345